Rajeev Dadoo - 27 Jun 2023 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director
Signature
/s/ Sasha Keough, attorney-in-fact for Rajeev Dadoo
Issuer symbol
SPRY
Transactions as of
27 Jun 2023
Net transactions value
$0
Form type
4
Filing time
28 Jun 2023, 21:03:55 UTC
Previous filing
10 Nov 2022
Next filing
24 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 27 Jun 2023 Common Stock 40,000 $6.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.